We're making a batch of trades — trimming 3 stocks and buying 2 others

Jim Cramer's Charitable Trust made strategic portfolio adjustments, trimming positions in Abbott Laboratories and Danaher due to anticipated prolonged headwinds from China's volume-based procurement program impacting diagnostics, and taking profits in Eaton after its recent rally. Concurrently, the Trust increased exposure to Cisco Systems, citing its role in AI infrastructure and underappreciated subscription model, and added to TJX Companies on a recent pullback, reinforcing its conviction in the retailer's fundamental strength.

Analysis

A strategic portfolio rebalancing is underway, driven by near-term headwinds in the healthcare diagnostics sector and a bullish outlook on specific technology and consumer discretionary names. Positions in Abbott Laboratories (ABT) and Danaher (DHR) are being trimmed due to concerns over China's volume-based procurement (VBP) program, a government initiative to control healthcare costs. Abbott recently cut its full-year sales growth outlook, citing that these VBP-related issues in its diagnostics business will persist for several more quarters. Anticipating a similar negative impact, the position in Danaher is being reduced ahead of its earnings report, with analysts forecasting a potential incremental $30-$40 million hit to its full-year outlook. This de-risking from China exposure is accompanied by a profit-taking sale in Eaton (ETN), which recently hit a record high following strong results from European peers; the move aims to lock in a 67% gain and guard against the possibility that positive news is already priced in. Proceeds are being redeployed into Cisco Systems (CSCO) to increase exposure to the AI infrastructure buildout, a thesis supported by the company reaching its $1 billion AI order goal a quarter ahead of schedule and its underappreciated shift to higher-margin software subscriptions. Additionally, a position is being added in TJX Companies (TJX) on a recent 6% pullback from its post-earnings high, capitalizing on what is viewed as a buying opportunity for a fundamentally strong retailer gaining share from weaker competitors.

Key Decisions for Investors

• Investors with exposure to the medical diagnostics sector should closely monitor earnings for commentary on China's volume-based procurement program, which is emerging as a persistent multi-quarter headwind for companies like Abbott and Danaher.
• Consider looking beyond semiconductor manufacturers for AI exposure and evaluate networking equipment providers like Cisco, which are demonstrating strong AI-related order growth and improving margin profiles from software transitions.
• It may be prudent to trim positions in stocks that have reached new highs on sector-wide optimism, such as Eaton, to realize gains before their individual earnings reports, while using pullbacks in fundamentally sound companies like TJX as tactical entry points.